| ziprasidone / Generic mfg. |
2006-004891-10: Future strategies for vocational rehabilitation schizophrenia |
|
|
| Ongoing | 4 | 100 | Europe | Ziprasidon, Risperidon, Capsule, hard, Film-coated tablet, Zeldox Hartkapseln, Risperdal | Charité - Universitätsmedizin Berlin | The social implications and long-term consequences of mental disorders regarding sick days at work, unemployment rates and early retirement are considerable. This trial is being conducted to understand whether and how atypical antipsychotic treatment effects long-term job rehabilitation in daily life and 2) and whether, how and which social psychiatric strategies (job consulting, vocational services, work rehabilitation, individual cognitive training) support or amplify these beneficial effects. | | | | |
| Completed | 4 | 3000 | | Perphenazine 16-64 mg/d (N=250) or Haloperidol 6-20 mg/d (N=250) ;Risperidone 2-6mg/d ;Olanzapine 5-20 mg/d ;Quetiapine 400-750mg/d ;Aripiperazole 10~30 mg/d ;Ziprasidone 80-160 mg/d | The Sixth Hospital / Institute of Mental Health, Peking University; The Ministry of Science and Technology, The National High Technology Research and Development Program of China (863 program) | Schizophrenia | | | | |
ChiCTR2200060542: A 16-Week, Randomized, Open label, Haloperidol-Controlled Study to Evaluate the Efficacy of Ziprasidone in Improving Social Cognitive Function of Patients with Schizophrenia |
|
|
| Completed | 4 | 60 | | Ziprasidone treatment ;Haloperidol treatment | Beijing Anding Hospital, Capital Medical University; Beijing Anding Hospital, Capital Medical University, Pfizer Inc. | Schizophrenia | | | | |
ChiCTR-RNC-09000521: The genetic association study on individual difference of therapeutic effects of antipsychotic medication |
|
|
| Completed | 4 | 2100 | | Risperidone 2-6mg/d; Olanzapine 5-20mg/d; Qutiapine 400-750mg/d; Ziprasidone 80-160 mg/d; Aripiprazole 10-30mg/d; Clozapine 200-600 mg/d; Perphenazine 20-60 mg/d | Sixth Hospital, Peking University; Ministry of Health, China, Ministry of Health, China. | schizophrenia | | | | |
2004-004482-15: Hirnaktivierung während Gedächtnisaufgaben bei Patienten mit Schizophrenie unter Behandlung von Ziprasidon oder Risperidon. Eine FMRT-Untersuchung. |
|
|
| Ongoing | 4 | 28 | Europe | Ziprasidon (Zeldox), Risperidon (Risperdal) Tablette, Risperidon (Risperdal) Lösung, Risperidon (Risperdal) Quicklet, Risperidon (Risperdal) Consta, Zeldox, Risperidon (Risperdal), Zeldox, Risperidon (Risperdal) | Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie | Patienten mit DSM-IVTR diagnostizierter Schizophrenie | | | | |
2005-003156-35: Efficacy and tolerability of Ziprasidone vs. Clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and cannabis use disorder: A randomised study |
|
|
| Ongoing | 4 | 50 | Europe | Ziprasidon HCl 20 mg Capsules, Clozapine 25 mg tablets, Ziprasidon HCl 40 mg Capsules, Ziprasidon HCl 60 mg Capsules, Ziprasidon HCl 80 mg Capsules, Clozapine 50 mg tablets, Clozapine 100 mg tablets, Zeldox, Elcrit, Zeldox(R), 20 mg Hartkapseln, Elcrit (R), 25 mg Tabletten, Zeldox(R), 40mg Hartkapseln, Zeldox(R), 60mg Hartkapseln, Zeldox(R), 80mg Hartkapseln, Elcrit (R), 50 mg Tabletten, Elcrit (R), 100 mg Tabletten, Zeldox(R), 20 mg Hartkapseln, Elcrit (R), 25 mg Tabletten, Zeldox(R), 40mg Hartkapseln, Zeldox(R), 60mg Hartkapseln, Zeldox(R), 80mg Hartkapseln, Elcrit (R), 50 mg Tabletten, Elcrit (R), 100 mg Tabletten | Department of Psychiatry and Psychotherapy (Cologne) | Patients with schizophrenia and cannabis abuse/dependency will be randomized to ziprasidone or clozapine treatment. Dose of medication and frequency of administration will be flexible and adjustable depending on clinical requirements. Duration of therapeutic trial:12 months | | | | |
2005-004501-28: Study to compare the efficacy of ziprasidone (Zeldox) and aripiprazole (Abilify) on cognitive functioning and quality of sleep in the treatment of schizophrenic patients |
|
|
| Ongoing | 4 | 60 | Europe | Ziprasidone, Aripiprazol, Zeldox 80mg, Abilify 10mg, Zeldox 40mg, Abilify 15mg, Zeldox 80mg, Abilify 10mg, Zeldox 40mg, Abilify 15mg | Department of Psychiatry, Ludwig-Maximilians-University Munich | Schizophrenia | | | | |
ChiCTR-OPC-15007529: Comparasion of metabolic side-effect of olanzapine or ziprasidone monotherapy, ziprasidone replacement andziprasidone joint olanzapine treatment on schizophrenia or schizophrennia like patients— an opne, controlled study |
|
|
| Not yet recruiting | 4 | 120 | | Treat with Ziprazidone ;Treat with Olanzapine ;Treat with olanzapine at the first week and then replaced by ziprazidone ;Treat with ziprazidone and olanzapine combindly | The department of psychiatry, Xijing Hospital; Xijing Hospital, From the department of psychiatry. | schizophrenia | | | | |
ChiCTR1900023483: Clinical Observation of the Efficacy and Safety of Ziprasidone Mesylate for Injection Combined with Oral Antipsychotics in the Treatment of Agitation Symptoms of Schizophrenia: A Multicenter Study in Shaanxi Area |
|
|
| Recruiting | 4 | 140 | | Ziprasidone Mesylate for Injection Combined With Olanzapine, Aripiprazole ;Ziprasidone Mesylate for Injection Sequential Olanzapine, Aripiprazole, Ziprasidone | Xi'an Mental Health Center; Xi'an Mental Health Center, Self-financing | Schizophrenia | | | | |
NCT04446234: Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building |
|
|
| Not yet recruiting | 4 | 350 | RoW | Risperidone, Aripiprazole, Ziprasidone, Amisulpride, Quetiapine | Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine | Schizophrenia | 12/22 | 12/22 | | |
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine |
|
|
| Recruiting | 4 | 60 | US | Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics | Ohio State University | Treatment-resistant Schizophrenia | 03/26 | 06/26 | | |
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung) |
|
|
| Ongoing | 3 | 1000 | Europe | Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor | Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM | therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT06482554: Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. |
|
|
| Recruiting | 3 | 80 | US | Lumateperone 42 mg, Lumateperone, Risperidone 2 mg, olanzapine; quetiapine; ziprasidone; aripiprazole | Louisiana State University Health Sciences Center Shreveport | Apathy, Schizophrenia, Schizophrenia; Psychosis | 12/26 | 12/26 | | |
2021-001333-38: Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis of schizophrenia. Ensayo clínico para estudiar el efecto que tiene un fármaco ya autorizado en otras patologías administrándolo en personas con reciente diagnóstico de esquizofrenia. |
|
|
| Not yet recruiting | 2/3 | 50 | Europe | VORTIOXETINA, HALOPERIDOL, Pimozida, Olanzapina, Risperidona, Chlorpromazine, Thioridazine, Quetiapine, Ziprasidone, aripiprazole, N06AX26, N05AD01, NO5AG02, NO5A H03, NO5AX08, N05AA01, N05AC02, N05AH04, N05AE04, N05AX12, Tablet, Capsule, hard, BRINTELLIX | Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), Consejería de salud | Early schizophrenia Esquizofrenia temprana, Newly evolving schizophrenia Esquizofrenia de reciente evolución, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT03781115: Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia |
|
|
| Recruiting | 1 | 24 | US | Ziprasidone, Geodon, Olanzapine, Zyprexa, Placebo Comparator, Placebo Oral Capsule | University of Arizona, Sidney R. Baer, Jr. Foundation | Schizophrenia | 12/22 | 01/23 | | |
NCT06040944: Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients |
|
|
| Completed | N/A | 64 | RoW | antipsychotic drugs inducing hyperprolactinemia, antipsychotic drugs not inducing hyperprolactinemia | Fayoum University | Schizophrenia Spectrum and Other Psychotic Disorders, Periodontal Diseases | 10/22 | 11/22 | | |
ChiCTR2200066688: Pre-experiment of human bioequivalence of ziprasidone mesylate for registration |
|
|
| Not yet recruiting | N/A | 12 | | First cycle test preparation T, second cycle reference preparation R; First cycle reference preparation Rest preparation T, second cycle test preparation T | Center for Clinical Pharmacology, the Third Xiangya Hospital of Central South University; Center for Clinical Pharmacology, the Third Xiangya Hospital of Central South University, Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. | agitation | | | | |
| Recruiting | N/A | 200 | US | Antipsychotics, Non-antipsychotic medication, Antidepressants, Benzodiazepines, No Medication | Icahn School of Medicine at Mount Sinai, Erasmus Medical Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Antipsychotics, Pregnancy | 06/27 | 12/27 | | |
